Title:
アリピプラゾールの投与方法
Document Type and Number:
Japanese Patent JP5300194
Kind Code:
B2
Abstract:
The present invention relates, in part, to the discovery that a pharmaceutical composition comprising aripiprazole and a carrier administered in a bolus injection resulted in an extended release profile similar to that obtained by the injection of a polylactide-co-glycolide microsphere formulation containing the active agent. This surprising result provides pharmacologically beneficial extended release formulations without the complexities and expense associated with the manufacture of microspheres.
More Like This:
| JP2022549866 | 2H-benzopyran derivatives as CRAC inhibitors |
| JP4238029 | Oxybenzamide derivative as a factor Xa inhibitor |
| WO/2006/042289 | SUBSTITUTED BIARYL QUINOLIN-4-YLAMINE ANALOGUES |
Inventors:
Brown, yosia
Application Number:
JP2006522614A
Publication Date:
September 25, 2013
Filing Date:
July 29, 2004
Export Citation:
Assignee:
Arcames, Inc.
International Classes:
A61K31/497; A61K9/08; A61K31/496; A61K47/02; A61K47/10; A61K47/26; A61K47/34; A61K47/38; A61P25/18; A61P43/00
Domestic Patent References:
| JP2191256A |
Other References:
村田敏郎他編,薬剤学 改訂第5版,南江堂,1997年,p98-101
Floyd and Jain,Chapter7. Injectable Emulsions and Susprnsions,PHARMACEUTICAL DOSAGE FORMS:Dispersr Systems, Vol.2 2nd ed,Marcel Dekker, Inc.,1996年,p.288-289
R.A.Nash,Chapter5. Pharmaceutical Suspensions,PHARMACEUTICAL DOSAGE FORMS:Disperse Systems, Vol.1,Marcel Dekker, Inc.,1988年,p152-155
Floyd and Jain,Chapter7. Injectable Emulsions and Susprnsions,PHARMACEUTICAL DOSAGE FORMS:Dispersr Systems, Vol.2 2nd ed,Marcel Dekker, Inc.,1996年,p.288-289
R.A.Nash,Chapter5. Pharmaceutical Suspensions,PHARMACEUTICAL DOSAGE FORMS:Disperse Systems, Vol.1,Marcel Dekker, Inc.,1988年,p152-155
Attorney, Agent or Firm:
Yoshinori Hosoda